Literature DB >> 3983959

Expression of receptors for Fc portion of IgM (Fc mu . R) and surface neuraminic acid on the human peripheral lymphocytes.

S Kataoka, T Kikuchi, T Toyota.   

Abstract

The purpose of this investigation is to establish a method of quantitation of sialic acid on the lymphocyte membrane surface and to clarify the importance of sialic acid in the functional manifestation of the lymphocyte receptor for the Fc portion of IgM (Fc mu . R) as well as the cell surface. The experiments yielded results leading to the following conclusions: Cell surface sialic acid can be exclusively recovered at consistent rates by treatment of lymphocytes with 0.1 IU of neuraminidase in the presence of Ca++ at 37 degrees C for 30 min. The sialic acid obtained, though in minute quantities, was accurately quantitated by the TBA method. By these procedures, the amount of sialic acid present on the cell membrane of human peripheral blood lymphocytes was determined to be 2.46 micrograms/10(7). Surface sialic acid on lymphocytes cultured at 37 degrees C after treatment with neuraminidase was resynthesized sufficiently at about 6 hr. On the cell membrane of lymphocytes deprived of Fc mu . R by treatment with neuraminidase, the receptor for IgM Fc became redetectable following incubation of the cells at 37 degrees C; the time-course of redevelopment of Fc mu . R showed a striking coincidence with that of sialic acid resynthesis. A sufficient redevelopment of Fc mu . R occurred in 6 hr of incubation of neuraminidase-treated Fc mu . R-deprived lymphocytes; the time required for sufficient redevelopment was comparable to that reported for pronase-treated lymphocytes. It is concluded from these findings that Fc mu . R deprived of sialic acid is no longer repaired while the receptor is resynthesized de novo on incubation of lymphocytes under adequate conditions.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3983959     DOI: 10.1620/tjem.145.73

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  2 in total

1.  In situ trans ligands of CD22 identified by glycan-protein photocross-linking-enabled proteomics.

Authors:  T N C Ramya; Eranthie Weerapana; Lujian Liao; Ying Zeng; Hiroaki Tateno; Liang Liao; John R Yates; Benjamin F Cravatt; James C Paulson
Journal:  Mol Cell Proteomics       Date:  2010-02-19       Impact factor: 5.911

2.  Masking of CD22 by cis ligands does not prevent redistribution of CD22 to sites of cell contact.

Authors:  Brian E Collins; Ola Blixt; Alexis R DeSieno; Nicolai Bovin; Jamey D Marth; James C Paulson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-12       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.